BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Nonlinear Dynamics and LifeGels Ltd (Previously Gradipore Ltd) Enter Progressive Distribution Agreement

26th Juily 2004 - (Newcastle upon Tyne, UK)  Nonlinear Dynamics, a leading provider of bioinformatics solutions, has today announced a new distribution agreement with LifeGels (formerly Gradipore Ltd, New South Wales, Australia) to supply Nonlinear’s evaluation software to LifeGels customers worldwide.

Under the agreement, LifeGels is to distribute evaluation copies of Nonlinear’s TotalLab software with all pre-cast gel orders. Users who then upgrade to a full license of TotalLab will receive 4 boxes of LifeGels pre-cast gels at no additional cost.

TotalLab is a highly automated and flexible image analysis software package. It offers an integrated solution for all general image analysis requirements across a wide range of image analysis applications within the Life Science laboratory. Comprehensive modules facilitate 1D electrophoresis gel analysis, array analysis, colony counting and general image analysis, all within an easy to use, 'wizard-style' interface.

Steve Lundberg, President of LifeGels, said, “LifeGels has a history of innovation in electrophoresis with a range of patented products, and we are delighted to have entered this collaboration with Nonlinear. This agreement is based on the evolving customer synergies between Nonlinear and LifeGels clients. By adopting this progressive approach, users will enjoy shared benefits of these quality products. We see this as a new and exciting commercial agreement to bring our products directly to users at the sharp end of Life Science research.”

John Spreadbury, Group Sales and Marketing Director of Nonlinear Dynamics and CEO of Nonlinear USA Inc., said, “This agreement represents the latest development in Nonlinear’s expanding network of prestigious OEM and commercial partners. Nonlinear adopts a collaborative approach in growing our business globally while maintaining focus on delivering premium analysis solutions responsive to the requirements of leading edge research. We are giving scientists the opportunity to perform a full trial of the TotalLab platform because we are confident that the quality of the software will then speak for itself.”

- ENDS -

About Nonlinear Dynamics Ltd

Established in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics solutions to the life science industry. The Company’s innovative product portfolio comprises high-quality analysis and data mining tools for 1D and 2D electrophoresis gels and microarrays, the core technologies of genomics and proteomics. Nonlinear sells and supports its products through its UK headquarters, its USA office, and its global network of partners and OEM resellers.  

Contact: James Sykes, Group Marketing Manager

Tel: +44 191 230 2121; james.sykes@nonlinear.com; www.nonlinear.com

About Life Therapeutics Ltd

Life Therapeutics is a global biotechnology company that researches, develops, manufactures and markets separation technologies for the life sciences market, and blood clotting tests for genetic disorders for the health industry. Life Therapeutics’ technologies and products enable research, development and production of biological products from plants to humans and promote the detection of disease, and the manufacturing of pharmaceuticals.

Contact: Dan Sullivan, Director of Sales

Tel: +61 2 8977 9000; dan.sullivan@life-therapeutics.com; www.life-therapeutics.com

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.